These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 1330012)

  • 21. Ganciclovir implants: one year later.
    Cadman J
    GMHC Treat Issues; 1997; 11(4/5):3-6. PubMed ID: 11364375
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cytomegalovirus optic neuritis: characteristics, therapy and survival.
    Mansor AM; Li HK
    Ophthalmologica; 1995; 209(5):260-6. PubMed ID: 8570149
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Neurologic prognosis of cytomegalovirus polyradiculomyelopathy in AIDS.
    Cohen BA; McArthur JC; Grohman S; Patterson B; Glass JD
    Neurology; 1993 Mar; 43(3 Pt 1):493-9. PubMed ID: 8383823
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Two AIDS patients with life-threatening pancreatitis successfully treated, one with ganciclovir the other with foscarnet.
    Colebunders R; Van den Abbeele K; Fleerackers Y; Bols K; Lachenal M; Van Damme L
    Acta Clin Belg; 1994; 49(5):229-32. PubMed ID: 7992567
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Successful treatment of varicella zoster virus meningoencephalitis in patients with AIDS: report of four cases and review.
    Poscher ME
    AIDS; 1994 Aug; 8(8):1115-7. PubMed ID: 7986408
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Congenital Cytomegalovirus Pneumonitis and Treatment Response Evaluation Using Viral Load during Ganciclovir Therapy: a Case Report.
    Lee-Yoshimoto M; Goishi K; Torii Y; Ito Y; Ono H; Mori T; Kashiwa N; Hosokawa S; Shichino H
    Jpn J Infect Dis; 2018 Jul; 71(4):309-311. PubMed ID: 29709989
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cytomegalovirus ulcer. Successful treatment with valganciclovir.
    Lambert EM; Strasswimmer J; Lazova R; Antaya RJ
    Arch Dermatol; 2004 Oct; 140(10):1199-201. PubMed ID: 15492181
    [No Abstract]   [Full Text] [Related]  

  • 28. Oral ganciclovir effective for CMV.
    Grodeck B
    Posit Aware; 1995; ():9. PubMed ID: 11362580
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cytomegalovirus infection presenting as acute periodontal infection in a patient infected with the human immunodeficiency virus.
    Dodd CL; Winkler JR; Heinic GS; Daniels TE; Yee K; Greenspan D
    J Clin Periodontol; 1993 Apr; 20(4):282-5. PubMed ID: 8386196
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ganciclovir treatment of cytomegalovirus colitis in AIDS: a randomized, double-blind, placebo-controlled multicenter study.
    Dieterich DT; Kotler DP; Busch DF; Crumpacker C; Du Mond C; Dearmand B; Buhles W
    J Infect Dis; 1993 Feb; 167(2):278-82. PubMed ID: 8380610
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Cytomegalovirus leukoencephalitis regressive under ganciclovir].
    Taillan B; Thomas P; Ferrari E; Pesce A; Fuzibet JG; Dujardin P
    Presse Med; 1992 Aug 29-Sep 5; 21(27):1296. PubMed ID: 1332020
    [No Abstract]   [Full Text] [Related]  

  • 32. [Polymerase chain reaction in diagnosing cytomegalovirus infection in HIV-infected patients].
    Shipulina OIu; Shakhgil'dian VI; Shipulin GA; Kravchenko AV; Serebrovskaia LV; Pokrovskiĭ VV
    Vopr Virusol; 1998; 43(2):91-5. PubMed ID: 9606879
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Phosphonoformate for CMV retinitis in AIDS.
    Colucciello M
    Am J Med; 1995 Mar; 98(3):317-8. PubMed ID: 7872354
    [No Abstract]   [Full Text] [Related]  

  • 34. Consequences for the management of cytomegalovirus.
    Katlama C
    AIDS; 1996 Nov; 10 Suppl 1():S43-6. PubMed ID: 8970676
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Combined and alternating ganciclovir/foscarnet in HIV-related cytomegalovirus encephalitis.
    Peters M; Schürmann D; Pohle HD; Ruf B; Timm H
    Lancet; 1992 Oct; 340(8825):970. PubMed ID: 1357363
    [No Abstract]   [Full Text] [Related]  

  • 36. Guide to CMV management.
    Cheng B
    PI Perspect; 1996 Apr; (no 18):13-4. PubMed ID: 11363508
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Foscarnet. A reappraisal of its antiviral activity, pharmacokinetic properties and therapeutic use in immunocompromised patients with viral infections.
    Wagstaff AJ; Bryson HM
    Drugs; 1994 Aug; 48(2):199-226. PubMed ID: 7527325
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Population differences in ganciclovir clearance as determined by nonlinear mixed-effects modelling.
    Yuen GJ; Drusano GL; Fletcher C; Capparelli E; Connor JD; Lalezari JP; Drew L; Follansbee S; Busch D; Jacobson M
    Antimicrob Agents Chemother; 1995 Oct; 39(10):2350-2. PubMed ID: 8619596
    [TBL] [Abstract][Full Text] [Related]  

  • 39. CMV trials struggle to enroll.
    Cadman J
    GMHC Treat Issues; 1997 Sep; 11(9):4-5. PubMed ID: 11364750
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Current management of cytomegalovirus disease in patients with AIDS.
    Jacobson MA
    AIDS Res Hum Retroviruses; 1994 Aug; 10(8):917-23. PubMed ID: 7811543
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.